- Home
- HUDI vs COCP Comparison
HUDI vs COCP Comparison
Compare HUDI & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUDI
- COCP
- Stock Information
- Founded
- HUDI 2018
- COCP 2006
- Country
- HUDI China
- COCP United States
- Employees
- HUDI N/A
- COCP N/A
- Industry
- HUDI Steel/Iron Ore
- COCP Biotechnology: Pharmaceutical Preparations
- Sector
- HUDI Industrials
- COCP Health Care
- Exchange
- HUDI Nasdaq
- COCP Nasdaq
- Market Cap
- HUDI 18.8M
- COCP 15.7M
- IPO Year
- HUDI 2021
- COCP N/A
- Fundamental
- Price
- HUDI $1.45
- COCP $1.63
- Analyst Decision
- HUDI
- COCP Strong Buy
- Analyst Count
- HUDI 0
- COCP 1
- Target Price
- HUDI N/A
- COCP $7.00
- AVG Volume (30 Days)
- HUDI 22.4K
- COCP 27.4K
- Earning Date
- HUDI 06-13-2025
- COCP 05-15-2025
- Dividend Yield
- HUDI N/A
- COCP N/A
- EPS Growth
- HUDI N/A
- COCP N/A
- EPS
- HUDI 0.01
- COCP N/A
- Revenue
- HUDI $74,270,429.00
- COCP N/A
- Revenue This Year
- HUDI N/A
- COCP N/A
- Revenue Next Year
- HUDI N/A
- COCP N/A
- P/E Ratio
- HUDI $149.59
- COCP N/A
- Revenue Growth
- HUDI N/A
- COCP N/A
- 52 Week Low
- HUDI $1.26
- COCP $1.12
- 52 Week High
- HUDI $3.45
- COCP $3.26
- Technical
- Relative Strength Index (RSI)
- HUDI 50.14
- COCP 56.83
- Support Level
- HUDI $1.40
- COCP $1.55
- Resistance Level
- HUDI $1.50
- COCP $1.81
- Average True Range (ATR)
- HUDI 0.13
- COCP 0.15
- MACD
- HUDI -0.00
- COCP 0.02
- Stochastic Oscillator
- HUDI 16.67
- COCP 56.10
About HUDI Huadi International Group Co. Ltd.
Huadi International Group Co Ltd is a manufacturer of industrial stainless steel seamless pipes and tubes products. Its products are used in the oil & gas transmission, chemistry engineering, food processing, medical devices, aeronautics and astronautics, boiler, irrigation works construction, automobile and naval architecture, paper mill and mechanical industries. Company generates revenue from Sales of steel piping products. Products are exported to the United States, Mexico, Thailand, Singapore, Argentina, Taiwan, India, the Philippines, UAE and Canada. Geographically, majority revenue is generated from China.
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).